iwNHL 2019 | Genetic basis of immune evasion in lymphoid malignancies: more heterogenetity than we think?

John Gribben and Margaret Shipp

John Gribben, MD, DSc, FRCP, FRCPath, FMed Sci, Barts Cancer Institute, London, UK, and Margaret Shipp, MD, Dana-Farber Cancer Institute, Boston, MA, discuss the current classifications of lymphoma, and the genetics underlying the prognostic features of non-Hodgkin lymphoma at the 17th International Workshop on Non-Hodgkin Lymphoma held in Boston, MA. The speakers also discuss the issues of heterogeneity in diffuse large B-cell lymphoma.

Share this video